Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02643667
Title A Study of Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Lawrence Fong
Indications

prostate adenocarcinoma

Therapies

Ibrutinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.